← The SEC Ephemeris: the whole map
Accord BioPharma Inc. INTP1
In the graph: all 5 documents (11 pages).
- Application
- BLA 761147
- Ticker
- Accord BioPharma Inc.
- Product
- INTP1
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- August 5, 2025 · June 26, 2025 · March 13, 2025 · October 29, 2024 · April 5, 2024
From FDA letters and SEC filings. Not investment or medical advice.